PathoAI
PrivateLast Round
Series A
Aug 4, 2025
Total Funding Raised
$2.78M
Company Overview
PathoAI is a healthcare technology company that develops AI-powered products and digital solutions for pathology diagnostics and pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathoAI Comparables
Compare PathoAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hangzhou DiPath Technology Co., Ltd. | 87% | |
| Qritive | 86% | |
| DeepPath | 85% | |
PathoAI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 4, 2025 | ||||
| Angel | Nov 1, 2024 | ||||
| Angel | May 25, 2023 | ||||
| Angel | May 24, 2023 | ||||
| Pre Seed | Mar 16, 2021 |
PathoAI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yangzhou Balance Yichuang Venture Fund | Angel |
| Hangzhou Oufang Venture Capital Management | Series A, Angel |
| Taikun Fund | Angel |
PathoAI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PathoAI's valuation, stock price, and market status.